Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

DSM probiotic LAFTI L10 proves it's strength

DSM Coating Resins : 13 June, 2005  (New Product)
Recent research by DSM has confirmed the superior efficacy, stability and survival of DSM`s probiotic Lactobacillus acidophilus LAFTI L10. With the probiotic activity of many supplements significantly reduced by the time the capsule reaches the gastro-intestinal tract, the only place that really matters, the proven gastro-intestinal survival of LAFTI L10 will benefit both Dietary Supplement manufacturers and consumers.
Recent research by DSM has confirmed the superior efficacy, stability and survival of DSM`s probiotic Lactobacillus acidophilus LAFTI L10. With the probiotic activity of many supplements significantly reduced by the time the capsule reaches the gastro-intestinal tract, the only place that really matters, the proven gastro-intestinal survival of LAFTI L10 will benefit both Dietary Supplement manufacturers and consumers.

''Probiotic success depends on three key factors, efficacy of the probiotic strain selected, stability of the probiotic in the dietary supplement and survival in the human gastro-intestinal tract,' comments Nelleke van Oorschot, technical service officer of DSM Food Specialties. 'The efficacy of the LAFTI strain and its survival in the gastro-intestinal tract have already been demonstrated in several trials. With the latest results from stability trials, we are in a position to provide manufacturers with clear and transparent stability statements which define what residual cell count can be expected after storage at typical temperatures.'

DSM has dedicated considerable resource to developing the LAFTI range and more beneficial effects are investigated in on-going human clinical trials. The three LAFTI strains (Lactobacillus acidophilus LAFTI L10, Bifidobacterium lactis LAFTI B94 and Lactobacillus casei LAFTI L26) have been selected for their positive probiotic effect to the consumer, good stability and excellent survival in the gastro-intestinal tract. They also deliver a high level of colony forming units per gram and promise an excellent shelf life, making them a safe, scientifically-backed option for both manufacturers and consumers.

Currently, LAFTI L10 for Dietary Supplements is available via DSM Nutritional Products. LAFTI L10 for Food is available via DSM Food Specialties. For further product information please visit: www.lafti.com
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo